Espen Andre Haavardsholm
Espen Andre Haavardsholm publishes mostly in Rheumatology, Immunology and Nephrology, on topics such as Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Gout, Hyperuricemia, Uric Acid.
- World rank
- #192,056 of 7,710,434 ranked researchers
- Rank in Norway
- #1,083 of 33,005
- Works
- 310
- Citations
- 11k
- Citations per work
- 35.9
What does Espen Andre Haavardsholm research?
Espen Andre Haavardsholm's work is mostly in Medicine (58%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences17957.9%
- Medicine17957.9%
- Everything else10835.0%
- Life Sciences227.1%
- 1Rheumatology40% of their works
- 2Immunology7% of their works
- 3Nephrology5% of their works
- 4Surgery5% of their works
- 5Hematology4% of their works
- 6Radiology, Nuclear Medicine and Imaging4% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Gout, Hyperuricemia, Uric Acid
- Systemic Lupus Erythematosus Research
- Biosimilars and Bioanalytical Methods
- Autoimmune and Inflammatory Disorders Research
- Monoclonal and Polyclonal Antibodies Research
- Musculoskeletal synovial abnormalities and treatments
Which keywords describe Espen Andre Haavardsholm's research?
The keywords of their largest research topics: Cardiovascular Risk, Inflammation, Autoantibodies, Biological Therapy, Rheumatoid Arthritis, Monoclonal Antibodies, Ankylosing Spondylitis and Spondyloarthritis.
- Synovial Chondromatosis
- Therapeutic Antibodies
- Juvenile Idiopathic Arthritis
- Immunogenicity
- Systemic Lupus Erythematosus
- Uric Acid
- Spondyloarthritis
- Monoclonal Antibodies
- Biological Therapy
- Inflammation
- Cardiovascular Risk
- Autoantibodies
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Hyperuricemia
- Antiphospholipid Syndrome
- Biosimilars
- Hemophagocytic Lymphohistiocytosis
- Fc Receptors
- Pigmented Villonodular Synovitis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Cardiovascular Risk2522 topics
- Inflammation2522 topics
- Autoantibodies2482 topics
- Biological Therapy2061 topic
- Rheumatoid Arthritis2061 topic
- Monoclonal Antibodies632 topics
- Ankylosing Spondylitis491 topic
- Spondyloarthritis491 topic
- Hyperuricemia461 topic
- Uric Acid461 topic
- Antiphospholipid Syndrome421 topic
- Systemic Lupus Erythematosus421 topic
- Biosimilars411 topic
- Immunogenicity411 topic
- Hemophagocytic Lymphohistiocytosis321 topic
- Juvenile Idiopathic Arthritis321 topic
- Fc Receptors221 topic
- Therapeutic Antibodies221 topic
- Pigmented Villonodular Synovitis201 topic
- Synovial Chondromatosis201 topic
Where does Espen Andre Haavardsholm work?
Espen Andre Haavardsholm's main affiliation in the publication record is Diakonhjemmet Hospital, Norway.
How many publications and citations does Espen Andre Haavardsholm have?
OpenAlex counts 310 works and 11,117 citations for Espen Andre Haavardsholm, an h-index of 48, ranking #192,056 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Espen Andre Haavardsholm. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.